Cargando…
Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712523/ https://www.ncbi.nlm.nih.gov/pubmed/31420368 http://dx.doi.org/10.1182/bloodadvances.2019000741 |
| _version_ | 1783446697989373952 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6712523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67125232019-08-28 Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068. Blood Adv Erratum American Society of Hematology 2019-08-16 /pmc/articles/PMC6712523/ /pubmed/31420368 http://dx.doi.org/10.1182/bloodadvances.2019000741 Text en © 2019 by The American Society of Hematology |
| spellingShingle | Erratum Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068. |
| title | Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068. |
| title_full | Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068. |
| title_fullStr | Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068. |
| title_full_unstemmed | Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068. |
| title_short | Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068. |
| title_sort | abraham aa, john td, keller md, et al. safety and feasibility of virus-specific t cells derived from umbilical cord blood in cord blood transplant recipients. blood adv. 2019;3(14):2057-2068. |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712523/ https://www.ncbi.nlm.nih.gov/pubmed/31420368 http://dx.doi.org/10.1182/bloodadvances.2019000741 |